(AFX UK Focus) 2010-03-23 08:50 Merck KGaA to issue bonds regularly -CFO in paper

(AFX UK Focus) 2010-03-23 08:50 Merck KGaA to issue bonds regularly -CFO in paper
FRANKFURT, March 23 (Reuters) – German pharmaceutical company Merck KGaA expects to raise funds on the bond market on a regular basis, its chief financial officer said in a newspaper interview. “Under our (bond) programme we will regularly act as an issuer on the bond market,” Michael Becker told Boersen-Zeitung in an interview published on Tuesday. Last week, Merck issued a 3.2 billion euro ($4 …

Read more on Interactive Investor

Ageing: Much ado about ageing

Ageing: Much ado about ageing
Questions about a laboratory assay are making Sirtris, a high-profile biotechnology company, the talking point of the ageing field. Heidi Ledford investigates.

Read more on Nature

Big Pharma Wins Big in Health Care Reform

Big Pharma Wins Big in Health Care Reform
The Republicans look a sour lot this morning, but the pharmaceutical industry, which helps foot the campaign bills of a sizeable chunk of members of both parties, is delighted with the legislation, and with its Democratic friends in the White House and on the Hill.

Read more on Baltimore Chronicle & Sentinel

Quick-Med Technologies to License NIMBUS(R) Technology for Wound Dressings in India

Quick-Med Technologies to License NIMBUS(R) Technology for Wound Dressings in India
GAINESVILLE, Fla. — Quick-Med Technologies, Inc. announced today that it has signed a binding term sheet stipulating the key terms of a Patent and Technology License Agreement with Viridis BioPharma Pvt.

Read more on GlobeNewswire via Yahoo! Finance

State Drug Control Dept cancels 71 sales licences, suspends another 95 during February

State Drug Control Dept cancels 71 sales licences, suspends another 95 during February
Karnataka drugs control department has issued show cause notices to 226 sales outlets and five manufacturing plants for violation of Drugs & Cosmetics Act. Around 95 licenses have been suspended and 71 sales licenses cancelled. One manufacturing unit was issued stop production order.

Read more on PharmaBiz

Next Page »